Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $0.3313 is 6.87% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 0.332||$ 7.70|
|Low:||$ 0.32||$ 0.31|
Company Description (as filed with the SEC)
RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering and developing immuno-oncology therapeutics to treat cancer based on our self-delivering RNAi ("sd-rxRNA®") platform. Our sd-rxRNA compounds do not require a delivery vehicle to penetrate the cell and are designed to "silence," or down-regulate, the expression of a specific gene that may be over-expressed in a disease condition. This provides RXi with a distinct advantage in adoptive cell therapy, the Company's initial focus and approach to immuno-oncology. Prior to our acquisition of MirImmune Inc. ("MirImmune") in January 2017, the Company's principal activities consisted of the preclinical and clinical development of our sd-rxRNA compounds and topical immunotherapy agent in the areas of dermatology and ophthalmology. ... More ...
Nasdaq Official Price
Nov. 16, 2018
Nov. 16, 2018